The week in industry: UK government announces funding for NHS to combat cancer, Parkinson’s and dementia
Tubulis and Glycotope enter into antibody drug conjugate partnership, kidney transplant antibody treatment enters preclinical development and FDA gives breakthrough designation for novel cancer treatment.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>